Skip to contentI
Inspire Medical Systems, Inc.
I
INSPInspire Medical Systems, Inc. Q1 2024 · 10-Q
Revenue$164.01M$164.01M+28.2% vs Q1 2023 Net Income-$10.01M-$10.01MN/M vs Q1 2023 EPS Diluted-$0.34-$0.34N/M vs Q1 2023 Gross Profit$139,253,000+28.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
Operating Cash Flow$8,860,000N/M Free Cash Flowderived-$2,836,000N/M Margins · derivedGross margin84.9%+0.5 pt vs Q1 2023
Operating margin-9.3%+6.0 pt vs Q1 2023
Net margin-6.1%+6.0 pt vs Q1 2023
ended Mar 31, 2024 · filed May 7, 2024 · 37 d after period end